Moderna Inc MRNA Counterparty Arbutus Biopharma Secures Regulatory Catalyst Amid Settled LNP Licensing Agreement OSBC Old Second stock rises 19 percent following Q1 2026 results even as it misses analyst consensus EPS estimates Is Gold GROY stock a suitable buy candidate